Answers are grounded in this paper and cite their sources.
Introduction: Testicular metastases from prostate adenocarcinoma are uncommon manifestations of neoplastic spread.Although they may be identified incidentally in orchiectomy specimens obtained for androgen deprivation therapy, they can also present as symptomatic testicular masses, complicating the differential diagnosis with primary neoplasms and infectious processes.Case Report: A male patient diagnosed in 2011 with Gleason 10 (5+5) prostate adenocarcinoma underwent radiation therapy and androgen deprivation therapy with goserelin until 2014.In 2018, he presented with pain and left testicular edema.A scrotal ultrasound revealed a heterogeneous intratesticular lesion with solid and cystic components, measuring 4.9 × 2.1 cm, raising the possibility of a neoplasm or abscess.A left orchiectomy was performed, and pathological examination identified metastasis from prostate adenocarcinoma.A histopathological review and immunohistochemical study performed in 2019 corroborated the prostatic origin of the lesion, showing positivity for PSA and NKX3.1 and negativity for SALL4.The serum PSA level documented after surgery was 1.67 ng/mL.The patient resumed hormone therapy between 2019 and 2022.In 2025, he presented with elevated PSA levels and metastatic bone involvement, subsequently undergoing contralateral orchiectomy for androgen suppression.He currently has advanced disease and is being treated with abiraterone.Conclusion: Testicular metastasis should be considered in the differential diagnosis of testicular lesions in patients with a history of prostate cancer, even years after initial treatment.Histopathological evaluation, supplemented by immunohistochemistry, is essential for establishing the origin of the lesion.
No takes yet. Share an insight, caveat, or question.
Gula et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: